Dendritic cell adhesion is enhanced on endothelial cells preexposed to calcineurin inhibitors

被引:11
作者
Schlichting, CL
Schareck, WD
Weis, M
机构
[1] Univ Rostock, Dept Surg, Div Transplantat Surg, Sch Med,Univ Hosp, D-18055 Rostock, Germany
[2] Univ Munich, Dept Med, Div Cardiol, Univ Hosp Grosshadern, Munich, Germany
关键词
transplantation; cyclosporine A; tacrolimus; endothelium; chronic rejection; inflammation;
D O I
10.1097/01.fjc.0000175233.88207.de
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic rejection remains a major complication in solid organ transplantation. Host alloreactive T cells (TC) can be activated by donor dendritic cells (DCs; direct allorecognition) or by recipient DCs (indirect allorecognition). A fundamental aspect of DC function is vascular invasion to present donor antigens to recipient naive TC in secondary lymphoid organs. We investigated the impact of calcineurin inhibitors on DC binding and transmigration to allogeneic human microvascular endothelial cells (ECs) with and without blocking of specific adhesion molecules. Recipient immature DCs were generated by culturing CD14(+) human peripheral blood monocytes with GM-CSF and IL-4. DC adhesion and transmigration were investigated on allogeneic ECs preincubated with increasing concentrations of cyclosporine and tacrolimus. Experiments were repeated in the presence of blocking antibodies against LFA-1, PECAM-1, VCAM-1, and ICAM-1. Endothelial stimulation with cyclosporine A (100 and 300 ng/mL) and tacrolimus (15 ng/mL) significantly enhanced DC-EC adhesion and transmigration (P < 0.01). LFA-1 blockade on DCs significantly reduced cyclosporine- and tacrolimus-induced DC adhesion (P < 0.001). VCAM-1 blockade on ECs partially reversed cyclosporine-induced DC adhesion (P < 0.001), whereas DC adhesion under tacrolimus exposure was significantly decreased by ICAM-1 (P < 0.01) and PECAM-1 (P < 0.001) blockade. DC binding and transmigration on allogeneic ECs exposed to calcineurin inhibitors is concentration-dependently increased. Different adhesion molecule patterns on ECs are responsible for enhanced DC invasion under cyclosporine and tacrolimus exposure. We speculate that long-term immunosuppression mediates enhanced invasion of recipient DCs to the donor organ and therefore may aggravate chronic rejection.
引用
收藏
页码:250 / 254
页数:5
相关论文
共 27 条
  • [1] Distinct roles for LFA-1 and CD28 during activation of naive T cells: Adhesion versus costimulation
    Bachmann, MF
    McKallFaienza, K
    Schmits, R
    Bouchard, D
    Beach, J
    Speiser, DE
    Mak, TW
    Ohashi, PS
    [J]. IMMUNITY, 1997, 7 (04) : 549 - 557
  • [2] Effect of immunosuppressive agents on long-term survival of renal transplant recipients - Focus on the cardiovascular risk
    Boots, JMM
    Christiaans, MHL
    van Hooff, JP
    [J]. DRUGS, 2004, 64 (18) : 2047 - 2073
  • [3] Cos J, 2002, HAEMATOLOGICA, V87, P679
  • [4] Adhesion, transendothelial migration, and reverse transmigration of in vitro cultured dendritic cells
    D'Amico, G
    Bianchi, G
    Bernasconi, S
    Bersani, L
    Piemonti, L
    Sozzani, S
    Mantovani, A
    Allavena, P
    [J]. BLOOD, 1998, 92 (01) : 207 - 214
  • [5] DUMONT FJ, 1990, J IMMUNOL, V144, P251
  • [6] FK506 suppresses the mitogen-induced increase in lymphocyte adhesiveness to endothelial cells, but does not affect endothelial cell activation in response to inflammatory stimuli
    Karlsson, H
    Nassberger, L
    [J]. TRANSPLANTATION, 1997, 64 (08) : 1217 - 1220
  • [7] Dendritic cells in transplantation - Friend or foe?
    Lechler, R
    Ng, WF
    Steinman, RM
    [J]. IMMUNITY, 2001, 14 (04) : 357 - 368
  • [8] In vitro effects of cyclosporin A on the expression of adhesion molecules on human umbilical vein endothelial cells
    Markovic, S
    Raab, M
    Daxecker, H
    Griesmacher, A
    Karimi, A
    Müller, MM
    [J]. CLINICA CHIMICA ACTA, 2002, 316 (1-2) : 25 - 31
  • [9] MEYER DM, 1995, J IMMUNOL, V155, P3578
  • [10] Immuno suppression and transplant vascular disease: benefits and adverse effects
    Moien-Afshari, F
    McManus, BM
    Laher, I
    [J]. PHARMACOLOGY & THERAPEUTICS, 2003, 100 (02) : 141 - 156